Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Industry

News and features about the latest developments in optics with a focus on industry

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Diabetes medication may protect against glaucoma

Researchers have reported that a common type of diabetes medication, GLP-1R agonists, may lower eye disease risk

Pills
Pixabay/HeungSoon
New research published in British Journal of Ophthalmology has highlighted that a common class of diabetes medication may lower an individual’s risk of developing glaucoma by half.

Scientists from the University of Pennsylvania examined data relating to 1961 diabetic patients who had recently started taking GLP-1R agonists. They compared this information to the records of 4371 diabetic patients who were not taking this class of medication.

After 150 days, 0.5% of patients taking the medication had developed glaucoma, compared to 1.3% of patients developing the eye disease in the control group.

The authors highlighted: “Our findings support further investigations into the use of GLP-1R agonists in glaucoma prevention.”

The research is supported by another study in 2020 which revealed that this type of medication reduced neuroinflammation and prevented retinal ganglion cell death in mice.

Advertisement